Los Angeles Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Sell |
387,916
-603,597
| -61% | -$441K | ﹤0.01% | 1069 |
|
|
2025
Q1 | $800K | Sell |
991,513
-124,629
| -11% | -$101K | ﹤0.01% | 624 |
|
|
2024
Q4 | $1.54M | Buy |
1,116,142
+186,010
| +20% | +$257K | 0.01% | 500 |
|
|
2024
Q3 | $967K | Buy |
930,132
+720,672
| +344% | +$749K | ﹤0.01% | 661 |
|
|
2024
Q2 | $362K | Buy |
209,460
+13,250
| +7% | +$22.9K | ﹤0.01% | 949 |
|
|
2024
Q1 | $469K | Buy |
196,210
+59,390
| +43% | +$142K | ﹤0.01% | 890 |
|
|
2023
Q4 | $456K | Buy |
136,820
+61,722
| +82% | +$206K | ﹤0.01% | 898 |
|
|
2023
Q3 | $281K | Buy |
+75,098
| New | +$281K | ﹤0.01% | 976 |
|
|
2021
Q2 | – | Sell |
-101,460
| Closed | -$1.48M | – | 1551 |
|
|
2021
Q1 | $1.48M | Sell |
101,460
-72,860
| -42% | -$1.06M | 0.01% | 732 |
|
|
2020
Q4 | $3.03M | Sell |
174,320
-1,400
| -0.8% | -$24.3K | 0.01% | 529 |
|
|
2020
Q3 | $3.22M | Sell |
175,720
-22,561
| -11% | -$414K | 0.01% | 431 |
|
|
2020
Q2 | $3.54M | Buy |
198,281
+33,133
| +20% | +$592K | 0.02% | 471 |
|
|
2020
Q1 | $2.68M | Buy |
165,148
+63,781
| +63% | +$1.03M | 0.02% | 466 |
|
|
2019
Q4 | $1.83M | Buy |
101,367
+74,987
| +284% | +$1.35M | 0.01% | 674 |
|
|
2019
Q3 | $534K | Buy |
+26,380
| New | +$534K | ﹤0.01% | 968 |
|